MCW physician-scientists test new treatment for advanced prostate cancer.
Nathan Ledeboer, PhD, medical director and professor, praises teamwork and diversity amidst the last 2 years of the COVID-19 pandemic.
Dr. Kathleen Schmainda Receives Perfect Score on NCI MPI R01 to Establish a Consensus DSC-MRI Protocol
Kathleen M. Schmainda, PhD, professor of biophysics, collaborates with researchers from MCW, Brown University, Barrow Neurological Institute, and Mayo Clinic.
Mice engineered to produce human prolactin support growth and distant spread of estrogen receptor-positive breast tumors from patients.
Kathleen M. Schmainda, PhD, professor of biophysics, was awarded a five-year, $2.7 million new R01 grant from the National Cancer Institute.
MCW's successful diagnostic testing process for COVID-19 resulted from longstanding partnerships and relationships.
The MCW Tissue Bank received a three-year accreditation by the College of American Pathologists (CAP) in recognition of quality practices, efficient operations, and strong processing statistics. Congratulations to the program team on this milestone achievement!
The International Society of Urological Pathology issues guidelines for the practice of uropathology and provides educational opportunities for pathologists around the world.
MCW research team contributes to positive clinical trial results for myotubular myopathy gene therapy
Audentes Therapeutics, Inc., recently presented new positive data on ASPIRO, a Phase 1/2 clinical trial of AT132 for the treatment of X-linked Myotubular Myopathy. Early nonclinical translational studies and the pathological evaluation of muscle biopsies from ASPIRO have been performed in the laboratory of Michael W. Lawlor, MD, PhD.
Medical College of Wisconsin
Froedtert/Medical College Lab Building
9200 W. Wisconsin Ave.
Milwaukee, WI 53226-3522
(414) 805-6980 (fax)